Fibroids Uterine - Also Known As Uterine Leiomyomata
Fibroids uterine, also known as uterine leiomyomata, are common benign smooth muscle tumors that develop in the muscular layer of a woman’s uterus. Men do not develop fibroids uterine. This is specifically a gynecological condition that is detected through symptoms discovered on physical examination, through ultrasound investigation, and definitively diagnosed through pathological exam following biopsy or excision.
When fibroids uterine are left to develop unchecked they can cause complications in pregnancy and delivery. However, most fibroids uterine are left untreated unless they cause pain, excessive menstruation, or otherwise negatively impact a patient’s quality of life or function, such as by interfering with sexual intercourse, or causing urinary frequency.
Leiomyoma was one of the first cancerous tumors to be identified by specific histological markers by pathologists. It is a benign tumor that has a very low incidence of metastasis. This means that these benign tumors tend to stay in place, and they do not spread their genetic changes outside the self-contained tumor.
Fibroids Uterine Treatment
While one leiomyoma can be identified in a patient’s uterus, it is more common for more than one to be present. Women who are predisposed to develop fibroids uterine often develop more than one, a condition referred to as multiple leiomyoma. There is no pharmaceutical treatment for this condition. No drug has been proven effective in reducing the size of existing leiomyomata, or in inhibiting their incidence.
Surgical intervention is the only cure, meaning the excisional removal of the tumors, usually via laproscopic methods, though this can also be accomplished trans-vaginally by certified physicians. Myomectomy is a common gynecologic surgery with low incidence of complications. The discrete tumors are removed and retracted from the uterus and submitted to a pathology lab for further diagnosis. Because of the relatively limited symptoms that leiomyomata display in a patient, the diagnosis is usually a forgone conclusion, and pathologists consider the submitted tissue a low level specimen. The specimen's margins are not inked or marked nor examined for infiltration of surrounding uterine tissues. Usually, only one or two slides are prepared for microscopic examination to determine the nature of the neoplastic mutation involved in the tumor. When the pathologic diagnosis is benign leiomyoma, there is no need to investigate further according to current standards of care.
While a fibroid uterus can be a troubling condition for the women who suffer from it, it is not a malignant one. The disease causes some functional disability, and it can be associated with pelvic pain when the tumors are large or widespread. It is, however, easily treated by uncomplicated surgical intervention.
For more information on Fibroids Uterine, visit our website at www.biomediclabs.com/blog